Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators.

N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839.

2.

Inquiry-based and research-based laboratory pedagogies in undergraduate science.

Weaver GC, Russell CB, Wink DJ.

Nat Chem Biol. 2008 Oct;4(10):577-80. doi: 10.1038/nchembio1008-577. No abstract available.

PMID:
18800041

Supplemental Content

Loading ...
Support Center